203 related articles for article (PubMed ID: 12649398)
1. Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases.
Polgár A; Falus A; Koó E; Ujfalussy I; Seszták M; Szuts I; Konrád K; Hodinka L; Bene E; Mészáros G; Ortutay Z; Farkas E; Paksy A; Buzás EI
Rheumatology (Oxford); 2003 Apr; 42(4):522-7. PubMed ID: 12649398
[TBL] [Abstract][Full Text] [Related]
2. Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis.
Barreto G; Soininen A; Ylinen P; Sandelin J; Konttinen YT; Nordström DC; Eklund KK
Arthritis Res Ther; 2015 Dec; 17():379. PubMed ID: 26703441
[TBL] [Abstract][Full Text] [Related]
3. Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Rheumatology (Oxford); 2007 Aug; 46(8):1367-71. PubMed ID: 17569744
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
Khan F; Siddiqui AA
Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
[TBL] [Abstract][Full Text] [Related]
6. Anti-cyclic citrullinated peptide antibody determination in synovial fluid of psoriatic arthritis.
Spadaro A; Riccieri V; Scrivo R; Alessandri C; Valesini G
Clin Exp Rheumatol; 2007; 25(4):599-604. PubMed ID: 17888217
[TBL] [Abstract][Full Text] [Related]
7. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
8. Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage.
Cs-Szabó G; Roughley PJ; Plaas AH; Glant TT
Arthritis Rheum; 1995 May; 38(5):660-8. PubMed ID: 7538297
[TBL] [Abstract][Full Text] [Related]
9. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
10. Identification of autoantibodies against PsoP27 in synovial fluid derived from psoriatic arthritis and rheumatoid arthritis patients.
Slobodkin M; Polachek A; Furer V; Elkayam O; Gertel S
Scand J Clin Lab Invest; 2024 May; 84(3):211-217. PubMed ID: 38767606
[TBL] [Abstract][Full Text] [Related]
11. Serum and synovial fluid antibodies to collagen in rheumatic diseases: a review.
Verbruggen LA; Geerts A; Wisse E; Lapiere C
Clin Rheumatol; 1986 Dec; 5(4):440-4. PubMed ID: 3816091
[TBL] [Abstract][Full Text] [Related]
12. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
13. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis.
Tarkowski A; Klareskog L; Carlsten H; Herberts P; Koopman WJ
Arthritis Rheum; 1989 Sep; 32(9):1087-92. PubMed ID: 2775319
[TBL] [Abstract][Full Text] [Related]
14. The cleavage of biglycan by aggrecanases.
Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
[TBL] [Abstract][Full Text] [Related]
15. Functional autoantibodies against serpin E2 in rheumatoid arthritis.
Maciejewska-Rodrigues H; Al-Shamisi M; Hemmatazad H; Ospelt C; Bouton MC; Jäger D; Cope AP; Charles P; Plant D; Distler JH; Gay RE; Michel BA; Knuth A; Neidhart M; Gay S; Jüngel A
Arthritis Rheum; 2010 Jan; 62(1):93-104. PubMed ID: 20039430
[TBL] [Abstract][Full Text] [Related]
16. Correlation of synovial fluid interleukin 6 (IL-6) activities with IgG concentrations in patients with inflammatory joint disease and osteoarthritis.
Hermann E; Fleischer B; Mayet WJ; Poralla T; Meyer zum Büschenfelde KH
Clin Exp Rheumatol; 1989; 7(4):411-4. PubMed ID: 2591114
[TBL] [Abstract][Full Text] [Related]
17. Humoral immunity to link protein in patients with inflammatory joint disease, osteoarthritis, and in non-arthritic controls.
Austin AK; Hobbs RN; Anderson JC; Butler RC; Ashton BA
Ann Rheum Dis; 1988 Nov; 47(11):886-92. PubMed ID: 3207372
[TBL] [Abstract][Full Text] [Related]
18. The small proteoglycans decorin and biglycan in human articular cartilage of late-stage osteoarthritis.
Bock HC; Michaeli P; Bode C; Schultz W; Kresse H; Herken R; Miosge N
Osteoarthritis Cartilage; 2001 Oct; 9(7):654-63. PubMed ID: 11597178
[TBL] [Abstract][Full Text] [Related]
19. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
[TBL] [Abstract][Full Text] [Related]
20. Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.
Zou J; Zhang Y; Thiel A; Rudwaleit M; Shi SL; Radbruch A; Poole R; Braun J; Sieper J
Rheumatology (Oxford); 2003 Jul; 42(7):846-55. PubMed ID: 12730543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
